A federal judge’s decision to invalidate the F.D.A.’s approval of mifepristone could affect availability even in states where abortion is legal.
Author: David W. Chen and Ava Sasani
Advertisements
{
"slotId": "6845006044",
"unitType": "responsive",
"resize": "auto"
}